[Controlled double-blind clinical study of cinnametic acid, a new choleretic agent in hepatobiliary diseases].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001657:Biliary Dyskinesia / Q000188:drug therapy; D001660:Biliary Tract Diseases / Q000188:drug therapy*; D002756:Cholagogues and Choleretics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002769:Cholelithiasis / Q000188:drug therapy; D002934:Cinnamates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006525:Hepatitis, Viral, Human / Q000188:drug therapy; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010919:Placebos
D002756:Cholagogues and Choleretics; D002934:Cinnamates; D010919:Placebos
Studio clinico controllato a doppia cecità sull'acido cinnametico, un nuovo coleretico nelle affezioni epatobiliari.